Cargando…

Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement

Detalles Bibliográficos
Autores principales: Fleming, Andrew B., Raabe, Vanessa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187833/
https://www.ncbi.nlm.nih.gov/pubmed/32361326
http://dx.doi.org/10.1016/j.jcv.2020.104388
_version_ 1783527233124564992
author Fleming, Andrew B.
Raabe, Vanessa
author_facet Fleming, Andrew B.
Raabe, Vanessa
author_sort Fleming, Andrew B.
collection PubMed
description
format Online
Article
Text
id pubmed-7187833
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Science
record_format MEDLINE/PubMed
spelling pubmed-71878332020-04-28 Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement Fleming, Andrew B. Raabe, Vanessa J Clin Virol Article Elsevier Science 2020-06 2020-04-28 /pmc/articles/PMC7187833/ /pubmed/32361326 http://dx.doi.org/10.1016/j.jcv.2020.104388 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Fleming, Andrew B.
Raabe, Vanessa
Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement
title Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement
title_full Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement
title_fullStr Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement
title_full_unstemmed Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement
title_short Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement
title_sort current studies of convalescent plasma therapy for covid-19 may underestimate risk of antibody-dependent enhancement
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187833/
https://www.ncbi.nlm.nih.gov/pubmed/32361326
http://dx.doi.org/10.1016/j.jcv.2020.104388
work_keys_str_mv AT flemingandrewb currentstudiesofconvalescentplasmatherapyforcovid19mayunderestimateriskofantibodydependentenhancement
AT raabevanessa currentstudiesofconvalescentplasmatherapyforcovid19mayunderestimateriskofantibodydependentenhancement